BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38420672)

  • 1. Discovery of non-sulfonamide carbonic anhydrase IX inhibitors through structure-based virtual screening.
    Cheng T; Wang N; Wen R; Wang S; Zhang H; Cheng M
    Phys Chem Chem Phys; 2024 Mar; 26(11):8767-8774. PubMed ID: 38420672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
    Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors.
    Al-Wahaibi LH; Youssif BGM; Taher ES; Abdelazeem AH; Abdelhamid AA; Marzouk AA
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
    Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
    Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
    Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
    Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of benzene and benzothiazole-sulfonamide analogues as selective inhibitors of the tumor-associated carbonic anhydrase IX.
    Manzoor S; Angeli A; Zara S; Carradori S; Rahman MA; Raza MK; Supuran CT; Hoda N
    Eur J Med Chem; 2022 Dec; 243():114793. PubMed ID: 36201858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Pyridinium Salt Derivatives of 2-(Hydrazinocarbonyl)-3-phenyl-1H-indole-5- sulfonamide as Selective Inhibitors of Tumour-Related Human Carbonic Anhydrase Isoforms IX and XII.
    Güzel-Akdemir Ö; Demir-Yazıcı K; Vullo D; Supuran CT; Akdemir A
    Anticancer Agents Med Chem; 2022; 22(14):2637-2646. PubMed ID: 35135455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis.
    Salmas RE; Senturk M; Yurtsever M; Durdagi S
    J Enzyme Inhib Med Chem; 2016; 31(3):425-33. PubMed ID: 25950196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.